Clinical benefit of various HER2-directed regimens in gastrointestinal malignancies: a retrospective cohort study.
- DOI
- 10.1186/s12885-026-16309-3
- Published
- 2026 Jun 10
- Container
- BMC cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-026-16309-3,
title = {Clinical benefit of various HER2-directed regimens in gastrointestinal malignancies: a retrospective cohort study.},
author = {Khanna V and Vadde S and Henry AS and Johnson TP and Shaheen S and Heestand GM and Holden T and Chong CR and Goyal L and Fisher GA and Chen CT},
year = {2026},
journal = {BMC cancer},
doi = {10.1186/s12885-026-16309-3},
url = {https://doi.org/10.1186/s12885-026-16309-3}
}RIS
TY - JOUR TI - Clinical benefit of various HER2-directed regimens in gastrointestinal malignancies: a retrospective cohort study. AU - Khanna V AU - Vadde S AU - Henry AS AU - Johnson TP AU - Shaheen S AU - Heestand GM AU - Holden T AU - Chong CR AU - Goyal L AU - Fisher GA AU - Chen CT PY - 2026 JO - BMC cancer DO - 10.1186/s12885-026-16309-3 UR - https://doi.org/10.1186/s12885-026-16309-3 ER -
APA
V, K., S, V., AS, H., TP, J., S, S., GM, H., T, H., CR, C., L, G., GA, F., & CT, C. (2026). Clinical benefit of various HER2-directed regimens in gastrointestinal malignancies: a retrospective cohort study.. BMC cancer. https://doi.org/10.1186/s12885-026-16309-3
Source records
- pubmed · retrieved 2026-09-27T01:34:50.624Z